Literature DB >> 15121054

Spectral pattern complexity analysis and the quantification of voice normality in healthy and radiotherapy patient groups.

Christopher Moore1, Kathiresan Manickam, Terry Willard, Susan Jones, Nicholas Slevin, Steven Shalet.   

Abstract

Vocal fold functionality may alter in response to direct radiotherapy or indirectly by perturbation of the hypothalamic-pituitary axis. Perceptual assessment of voice quality is difficult to summarise in a single, reliable figure of normality and normality itself is undefined. In this study spectral analysis of vocal fold vibration, based on impedance variations measured across the larynx using an electro-glottogram, is used to build a single parameter description of standard vowel phonation in the normal male population. Patient data and perceptual assessment are then compared to this standard. The spectral pattern of the vowel/i/ electro-glottogram time series is analysed using approximate entropy after dynamic fundamental-harmonic frequency normalisation. The approximate entropy provides a single estimate of the spectral pattern complexity. A cohort of 89 normal males formed two statistically distinct groups, G1, with strong spectral pattern and high complexity 0.338 (+/-0.036), and G2 with a weak spectral pattern and low complexity 0.175 (+/-0.049). Membership ratio G1:G2 was 2:1. A cohort of 30 male larynx cancer cases were analysed approximately 3-6 months after irradiation, and three male prophylactic cranial irradiation cases some years after treatment. Two-thirds of patients had G2 or lower levels of complexity. The lower G2 complexity level appears to be the subjective, as well as the objective, threshold for voice normality.

Entities:  

Mesh:

Year:  2004        PMID: 15121054     DOI: 10.1016/j.medengphy.2004.01.005

Source DB:  PubMed          Journal:  Med Eng Phys        ISSN: 1350-4533            Impact factor:   2.242


  1 in total

Review 1.  Automated delineation of radiotherapy volumes: are we going in the right direction?

Authors:  G A Whitfield; P Price; G J Price; C J Moore
Journal:  Br J Radiol       Date:  2013-01       Impact factor: 3.039

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.